Literature DB >> 11152493

Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

R J Jackson1, A J Ramsay, C D Christensen, S Beaton, D F Hall, I A Ramshaw.   

Abstract

Genetic resistance to clinical mousepox (ectromelia virus) varies among inbred laboratory mice and is characterized by an effective natural killer (NK) response and the early onset of a strong CD8(+) cytotoxic T-lymphocyte (CTL) response in resistant mice. We have investigated the influence of virus-expressed mouse interleukin-4 (IL-4) on the cell-mediated response during infection. It was observed that expression of IL-4 by a thymidine kinase-positive ectromelia virus suppressed cytolytic responses of NK and CTL and the expression of gamma interferon by the latter. Genetically resistant mice infected with the IL-4-expressing virus developed symptoms of acute mousepox accompanied by high mortality, similar to the disease seen when genetically sensitive mice are infected with the virulent Moscow strain. Strikingly, infection of recently immunized genetically resistant mice with the virus expressing IL-4 also resulted in significant mortality due to fulminant mousepox. These data therefore suggest that virus-encoded IL-4 not only suppresses primary antiviral cell-mediated immune responses but also can inhibit the expression of immune memory responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152493      PMCID: PMC114026          DOI: 10.1128/JVI.75.3.1205-1210.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  A role for early cytotoxic T cells in resistance to ectromelia virus infection in mice.

Authors:  H C O'Neill; M Brenan
Journal:  J Gen Virol       Date:  1987-10       Impact factor: 3.891

2.  A case for cytokines as effector molecules in the resolution of virus infection.

Authors:  A J Ramsay; J Ruby; I A Ramshaw
Journal:  Immunol Today       Date:  1993-04

Review 3.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

4.  Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.

Authors:  M K Spriggs; B H Koller; T Sato; P J Morrissey; W C Fanslow; O Smithies; R F Voice; M B Widmer; C R Maliszewski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

5.  Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2.

Authors:  G Karupiah; B E Coupar; M E Andrew; D B Boyle; S M Phillips; A Müllbacher; R V Blanden; I A Ramshaw
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

6.  Differentiation of human NK cells into NK1 and NK2 subsets.

Authors:  D Peritt; S Robertson; G Gri; L Showe; M Aste-Amezaga; G Trinchieri
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

7.  Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells.

Authors:  F Erard; M T Wild; J A Garcia-Sanz; G Le Gros
Journal:  Science       Date:  1993-06-18       Impact factor: 47.728

8.  Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins.

Authors:  K Mossman; C Upton; R M Buller; G McFadden
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

9.  Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon.

Authors:  G P Bembridge; J A Lopez; R Cook; J A Melero; G Taylor
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

10.  Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production.

Authors:  A D'Andrea; X Ma; M Aste-Amezaga; C Paganin; G Trinchieri
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  139 in total

1.  Creation of killer poxvirus could have been predicted.

Authors:  A Müllbacher; M Lobigs
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  PNAS policy on publication of sensitive material in the life sciences.

Authors:  Nicholas R Cozzarelli
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-15       Impact factor: 11.205

Review 3.  Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.

Authors:  Gavin C Bowick; Alexander J McAuley
Journal:  Bioeng Bugs       Date:  2011-05-01

4.  Advances in life sciences and bioterrorism. Risks, perspectives and responsibilities.

Authors:  Volker Beck
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

Review 5.  Emergency department response to the deliberate release of biological agents.

Authors:  J E Ollerton
Journal:  Emerg Med J       Date:  2004-01       Impact factor: 2.740

6.  A stimulating way to improve T cell responses to poxvirus-vectored vaccines.

Authors:  Stuart N Isaacs
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

7.  A Hippocratic Oath for life scientists. A Hippocratic-style oath in the life sciences could help to educate researchers about the dangers of dual-use research.

Authors:  James Revill; Malcolm R Dando
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

8.  Characterization of ectromelia virus deficient in EVM036, the homolog of vaccinia virus F13L, and its application for rapid generation of recombinant viruses.

Authors:  Felicia Roscoe; Ren-Huan Xu; Luis J Sigal
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

9.  Protective effect of exogenous recombinant mouse interferon-gamma and tumour necrosis factor-alpha on ectromelia virus infection in susceptible BALB/c mice.

Authors:  A V Atrasheuskaya; E K Bukin; T M Fredeking; G M Ignatyev
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

10.  Genetic basis for adverse events after smallpox vaccination.

Authors:  David M Reif; Brett A McKinney; Alison A Motsinger; Stephen J Chanock; Kathryn M Edwards; Michael T Rock; Jason H Moore; James E Crowe
Journal:  J Infect Dis       Date:  2008-07-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.